K. Kerlin

1.3k total citations
11 papers, 115 citations indexed

About

K. Kerlin is a scholar working on Pulmonary and Respiratory Medicine, Radiation and Molecular Biology. According to data from OpenAlex, K. Kerlin has authored 11 papers receiving a total of 115 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pulmonary and Respiratory Medicine, 3 papers in Radiation and 2 papers in Molecular Biology. Recurrent topics in K. Kerlin's work include Prostate Cancer Treatment and Research (5 papers), Prostate Cancer Diagnosis and Treatment (5 papers) and Advanced Radiotherapy Techniques (3 papers). K. Kerlin is often cited by papers focused on Prostate Cancer Treatment and Research (5 papers), Prostate Cancer Diagnosis and Treatment (5 papers) and Advanced Radiotherapy Techniques (3 papers). K. Kerlin collaborates with scholars based in United States and Canada. K. Kerlin's co-authors include Howard M. Sandler, Seth A. Rosenthal, Sucha O. Asbell, Mark L. Sobczak, Kenneth J. Pienta, Raghu Rajan, Jeff M. Michalski, Kenneth L. Zeitzer, Alan C. Hartford and Karen Zempolich and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Radiation Oncology*Biology*Physics and Gynecologic Oncology.

In The Last Decade

K. Kerlin

11 papers receiving 110 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
K. Kerlin United States 7 79 25 21 20 14 11 115
N. Antoniou Greece 7 66 0.8× 13 0.5× 4 0.2× 9 0.5× 11 0.8× 15 125
Jacqueline Lam Canada 5 82 1.0× 20 0.8× 17 0.8× 37 1.9× 12 0.9× 9 126
E. Meyer France 4 117 1.5× 23 0.9× 45 2.1× 18 0.9× 5 0.4× 17 141
Tatiana Hadjieva Bulgaria 5 61 0.8× 18 0.7× 9 0.4× 19 0.9× 6 0.4× 7 154
Shivani Sud United States 6 24 0.3× 10 0.4× 20 1.0× 24 1.2× 31 2.2× 12 131
M. Rives France 7 116 1.5× 16 0.6× 27 1.3× 35 1.8× 8 0.6× 9 252
Catherine Lemon United Kingdom 6 53 0.7× 23 0.9× 27 1.3× 24 1.2× 6 0.4× 8 190
R.G.H.M. Cremers Netherlands 8 142 1.8× 37 1.5× 19 0.9× 35 1.8× 10 0.7× 16 222
B. Czeremszyńska Poland 4 79 1.0× 30 1.2× 22 1.0× 11 0.6× 17 1.2× 7 118
Petra Jankowska United Kingdom 4 24 0.3× 14 0.6× 6 0.3× 35 1.8× 34 2.4× 6 141

Countries citing papers authored by K. Kerlin

Since Specialization
Citations

This map shows the geographic impact of K. Kerlin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K. Kerlin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K. Kerlin more than expected).

Fields of papers citing papers by K. Kerlin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K. Kerlin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K. Kerlin. The network helps show where K. Kerlin may publish in the future.

Co-authorship network of co-authors of K. Kerlin

This figure shows the co-authorship network connecting the top 25 collaborators of K. Kerlin. A scholar is included among the top collaborators of K. Kerlin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K. Kerlin. K. Kerlin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
2.
Shipley, William U., Wendy Seiferheld, Himu Lukka, et al.. (2015). Report of NRG Oncology/RTOG 9601, A Phase 3 Trial in Prostate Cancer: Anti-androgen Therapy (AAT) With Bicalutamide During and After Radiation Therapy (RT) in Patients Following Radical Prostatectomy (RP) With pT2-3pN0 Disease and an Elevated PSA. International Journal of Radiation Oncology*Biology*Physics. 94(1). 3–3. 14 indexed citations
3.
Alexander, Brian M., Meihua Wang, W.K. Alfred Yung, et al.. (2012). A phase II study of conventional radiation therapy and thalidomide for supratentorial, newly-diagnosed glioblastoma (RTOG 9806). Journal of Neuro-Oncology. 111(1). 33–39. 13 indexed citations
6.
Zempolich, Karen, Brett Milash, Kathryn M. Greven, et al.. (2008). Changes in gene expression induced by chemoradiation in advanced cervical carcinoma: A microarray study of RTOG C-0128. Gynecologic Oncology. 109(2). 275–279. 13 indexed citations
7.
Gaffney, David K., Kathryn Winter, Kathryn M. Greven, et al.. (2005). Feasibility of RNA collection for micro-array gene expression analysis in the treatment of cervical carcinoma: a scientific correlate of RTOG C-0128. Gynecologic Oncology. 97(2). 607–611. 8 indexed citations
8.
Zempolich, Karen, Brett Milash, Kathryn M. Greven, et al.. (2005). Changes in Gene Expression Induced by Chemoradiation in Advanced Cervical Carcinoma: A Microarray Study of RTOG C-0128. International Journal of Radiation Oncology*Biology*Physics. 63. S96–S96. 1 indexed citations
9.
Sandler, Howard M., Michelle DeSilvio, Kenneth J. Pienta, et al.. (2005). Preliminary Analysis of RTOG 9902: Increased Toxicity Observed with the Use of Adjuvant Chemotherapy. International Journal of Radiation Oncology*Biology*Physics. 63. S123–S123. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026